Water vapor thermal therapy: Technical variations among spanish hospitals and efficacy at 2-year follow-up.

BPH Benign prostatic hyperplasia HBP Hiperplasia benigna de próstata Minimally invasive surgical treatment Rezūm Terapia térmica con vapor de agua Tratamiento quirúrgico mínimamente invasivo Water vapor thermal therapy

Journal

Actas urologicas espanolas
ISSN: 2173-5786
Titre abrégé: Actas Urol Esp (Engl Ed)
Pays: Spain
ID NLM: 101771154

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 27 04 2023
accepted: 03 05 2023
medline: 5 12 2023
pubmed: 10 7 2023
entrez: 9 7 2023
Statut: ppublish

Résumé

The aim of this work is to evaluate the initial experience with water vapor thermal therapy (WVTT) for benign prostatic hyperplasia (BPH) in Spanish university hospitals, as well as to describe the differences in technique and follow-up between centers. This retrospective observational multicenter study collected baseline characteristics, surgical, postoperative and follow-up data at 1, 3, 6, 12 and 24 months, including validated questionnaires, flowmetric variations, complications, and the need for pharmacological or surgical treatment following the procedure. Possible triggers for postoperative acute urinary retention (AUR) were also analyzed. A total of 105 patients were included. No differences were observed between the groups with and without AUR with respect to catheterization time (5 and 4.3 days respectively, P=.178), or prostate volume (47.9g and 41.4g respectively, P=.147). The mean improvement at 3, 6, 12 and 24 months in terms of peak flow was 5.3, 5.2, 4.2 and 3.8ml/s, respectively. As for ejaculation, an improvement was observed after 3 months of follow-up and was maintained over time. Minimally invasive treatment for BPH with WVTT shows good functional outcomes at 24 months follow-up, without significant impairment of sexual function and a low incidence of complications. There are minor inter-hospital variations, mainly in the immediate postoperative period.

Identifiants

pubmed: 37423384
pii: S2173-5786(23)00086-0
doi: 10.1016/j.acuroe.2023.07.001
pii:
doi:

Substances chimiques

Steam 0

Types de publication

Observational Study Multicenter Study Journal Article

Langues

eng spa

Sous-ensembles de citation

IM

Pagination

668-674

Informations de copyright

Copyright © 2023 AEU. Published by Elsevier España, S.L.U. All rights reserved.

Auteurs

I Schwartzmann (I)

Servicio de Urología de la Fundació Puigvert, Barcelona, Spain. Electronic address: ivanschwartzmann@gmail.com.

S García Barreras (S)

Servicio de Urología, Hospital Ramon y Cajal, Madrid, Spain.

M D'Anna (M)

Servicio de Urología, Hospital Clínic, Barcelona, Spain.

V Parejo (V)

Servicio de Urología, Hospital de Girona Dr. Josep Trueta, Gerona, Spain.

I Torneo Ruiz (I)

Servicio de Urología, Hospital Virgen de la Arrixaca, Murcia, Spain.

A C Tagalos Muñoz (AC)

Servicio de Urología, Hospital Ramon y Cajal, Madrid, Spain.

A Bravo-Balado (A)

Servicio de Urología de la Fundació Puigvert, Barcelona, Spain.

P Diana (P)

Servicio de Urología de la Fundació Puigvert, Barcelona, Spain.

L Peri (L)

Servicio de Urología, Hospital Clínic, Barcelona, Spain.

M Domínguez Esteban (M)

Servicio de Urología, Hospital Universitario Marqués de Valdecillas, Santander, Spain.

E Fernández Guzmán (E)

Servicio de Urología, Hospital Universitario Marqués de Valdecillas, Santander, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH